Encore Capital Group Announces Fourth Quarter and Full-Year 2025 Financial Results SAN DIEGO, February 25, 2026 -- Encore Capital Group, Inc. (NASDAQ: ECPG), an international specialty finance company, today reported consolidated financial results for the fourth quarter and full year ended December 31, 2025. "Encore's industry leadership and operational innovation are on full display after delivering very strong 2025 financial results," said Ashish Masih, Encore's President and Chief Executive Officer. "Wit ...

TWFG Announces Fourth Quarter and Full Year 2025 Results – Total Revenues increased 33.0% for the quarter over the prior year period to $68.8 million – – Organic Revenue Growth Rate* of 11.7% for the quarter – – Net income of $14.4 million for the quarter – – Adjusted EBITDA* increased 56.9% for the quarter over the prior year period to $21.7 million - – Share Repurchase Authorization approved for up to $50 million - THE WOODLANDS, Texas, February 25, 2026 (GLOBE NEWSWIRE) – TWFG, Inc. ("TWFG", the "Company ...

Amy Nanola, Owner of LOLA LOLA offers a curated selection of gifts, clothing, and accessories for shoppers across Northern California. Founded more than 20 years ago as a single storefront, the business has expanded to four high-traffic, tourist-driven locations where customer experience is critical, and where team members are the face of the business. For owner Amy Nanola, hiring isn't just an occasional task; it's a constant priority. "Hiring is the most important thing we do," she explains. "I'm never no ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40378 The Honest Company, Inc. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of (I.R.S. Employer ...

Exhibit 99.1 Red Robin Gourmet Burgers, Inc. Reports Results for the Fiscal Fourth Quarter and Fiscal Year Ended December 28, 2025 Englewood, CO – February 25, 2026 – Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) ("Red Robin" or the "Company"), a full-service restaurant chain serving an innovative selection of high-quality gourmet burgers in a family-friendly atmosphere, today reported financial results for the fiscal fourth quarter and year ended December 28, 2025. Chief Executive Officer Comments Dave Pa ...

Exhibit 99.1 Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results 2025 Total Revenue of $256 Million Strong Balance Sheet Supports Path to Positive Adjusted EBITDA by Year-End 2028 2025 Software Revenue of $200 Million; 2025 Software ACV of $198 Million Accelerating Transition to Ratable, Hosted Software Revenue | Software KPI | 2025 | 2024 | % Growth | | --- | --- | --- | --- | | Total annual contract value (ACV) | $198.5M | $190.8M | 4.0% | | Top 20 Pharma ACV | $80.8M | $70.0M | 15.3% ...

Financial Performance - License and collaboration revenue decreased by $163.2 million from $170.6 million in Q4 2024 to $7.4 million in Q4 2025, and decreased by $388.4 million from $434.4 million in 2024 to $46 million in 2025[12] - The net loss for Q4 2025 was $44.4 million, or $0.69 per share, compared to a net income of $131.7 million, or $2.11 per share, in Q4 2024[14] - Protagonist's total operating expenses for 2025 were $204.1 million, compared to $181.6 million in 2024[20] - Total stockholders' equity decreased to $614,707,000 in 2025 from $675,295,000 in 2024, a decline of approximately 9%[24] - The accumulated deficit increased to $(470,671,000) in 2025 from $(340,522,000) in 2024, indicating a worsening financial position[24] Cash and Assets - Protagonist reported cash, cash equivalents, and marketable securities of $646 million as of December 31, 2025, up from $559.2 million in the previous year[2] - Cash, cash equivalents, and marketable securities as of December 31, 2025, were $646,002,000, up from $559,165,000 in 2024, indicating a 16% increase[24] - Total assets decreased to $668,188,000 in 2025 from $744,725,000 in 2024, a decline of approximately 10%[24] - Deferred revenue significantly decreased to $9,550,000 in 2025 from $30,567,000 in 2024, a reduction of about 69%[24] Research and Development - Research and development expenses increased by $11.5 million in Q4 2025 compared to the prior year, primarily due to drug discovery and pre-clinical research expenses[11] - Research and development expenses for Q4 2025 were $6,121,000, up from $5,322,000 in Q4 2024, representing a 15% increase[22] - The Phase 1 study of PN-881 is expected to be completed by mid-2026, informing future clinical development plans[6] - Protagonist's pipeline includes new candidates PN-477, PN-458, and PN-8047, expanding its focus on obesity and hepcidin mimetics[2] Future Outlook - Protagonist expects to opt-out of the 50:50 profit and loss sharing arrangement for rusfertide with Takeda in Q2 2026[1] - The company anticipates a U.S. regulatory decision for ICOTYDE™ in 2026, with a potential launch this year if approved[1] - The company projects a cash runway through at least the end of 2028 based on current cash reserves[2] Expenses - General and administrative expenses for Q4 2025 were $4,580,000, compared to $3,771,000 in Q4 2024, reflecting a 21% increase[22] - Total stock-based compensation expense for Q4 2025 was $10,701,000, an increase of 18% from $9,093,000 in Q4 2024[22]

Exhibit 99.1 Zevia Announces Fourth Quarter and Full Year 2025 Results; Appoints Lead Independent Director, Andrew Ruben, to Chair of the Board LOS ANGELES – February 25, 2026 (BUSINESS WIRE) – Zevia PBC ("Zevia" or the "Company") (NYSE: ZVIA), the Company bringing naturally delicious, zero sugar, clean-label beverages, today reported results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Highlights Full Year 2025 Highlights "2025 was a pivotal year for Zevia. We gained ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-34571 PEBBLEBROOK HOTEL TRUST (Exact Name of Registrant as Specified in Its Charter) Maryland 27-1055421 (State of Incorporation or Organizatio ...

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ __________________________________________________________________________________________________FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period ...